<DOC>
	<DOCNO>NCT00942526</DOCNO>
	<brief_summary>Anastomotic leakage still major cause considerable morbidity mortality esophagectomy gastric pull esophageal carcinoma . Risk factor analyse anastomotic leakage , include blood supply , graft tension , comorbidity , perform , study produce strategy improve operative result . This study perform identify prognostic variable might use develop strategy optimize outcome esophagogastrectomy .</brief_summary>
	<brief_title>Oral Anti-Infective Agent Esophageal Anastomotic Leakage</brief_title>
	<detailed_description>Goal : The effect oral hygiene occurrence esophagogastric anastomotic leakage yet study along time . We use random cohort study model investigate effect perioperative oral anti-infective gargle agent esophagogastric anastomotic wound healing . Method : 1 . Design : One hundred twenty patient divide 3 group group 40 esophageal patient . Minimization stratify randomization apply . Oral anti-infective gargling agent , Mycostatin oral suspension , employ one week operation . The first group treat without oral gargle agent ; second group treat gargling water ; third group treat anti-infective gargling agent . An end-to-side two-layer esophagogastric anastomosis construct use interrupted suture metallic staple cervical wound . On hand , anastomotic leakage rate different group investigate . 2 . Data Collection Statistic Analysis : The record patient , various biologic parameter , management leakage analyze . Thirty-day morbidity mortality determine , stepwise multivariable logistic regression analysis ass effect preoperative postoperative variable anastomotic leakage . Time variation start oral feeding hospital stay compare use Kaplan-Meier method .</detailed_description>
	<mesh_term>Anastomotic Leak</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<mesh_term>Nystatin</mesh_term>
	<criteria>carcinoma esophagus , operable stage I III patient inoperable , patient obvious impaired blood supply gastric substitute , patient noncervical esophagogastrostomy .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>esophageal cancer</keyword>
	<keyword>anastomotic leakage</keyword>
	<keyword>Prevention anastomotic leakage esophageal surgery</keyword>
</DOC>